Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Daly

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|December 23, 2022
Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host DiseaseGaurav Tripathi, Rutvij A Khanolkar, Rehan M Faridi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbiditiesAndrew Daly, Mary L Savoie, Michelle Geddes, et al.
Clinical Transplantation|November 9, 2017
Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantationAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 15, 2014
High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host diseaseSumit Chawla, Poonam Dharmani-Khan, Yiping Liu, et al.
Cytotherapy|March 28, 2018
Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorderAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Acta Biomaterialia|March 3, 2019
Hypoxia mimicking hydrogels to regulate the fate of transplanted stem cellsBinulal N Sathy, Andrew Daly, Tomas Gonzalez-Fernandez, et al.
Cytotherapy|August 10, 2021
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulinRutvij A Khanolkar, Amit Kalra, Megan Kinzel, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
Clinical Transplantation|June 24, 2020
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low-dose total body irradiation, and rabbit antithymocyte globulinSamar Ousia, Amit Kalra, Tyler S Williamson, et al.
Transplantation and Cellular Therapy|October 4, 2021
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell TransplantationMegan Kinzel, Michelle Dowhan, Amit Kalra, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|December 23, 2022
Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host DiseaseGaurav Tripathi, Rutvij A Khanolkar, Rehan M Faridi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbiditiesAndrew Daly, Mary L Savoie, Michelle Geddes, et al.
Clinical Transplantation|November 9, 2017
Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantationAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 15, 2014
High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host diseaseSumit Chawla, Poonam Dharmani-Khan, Yiping Liu, et al.
Cytotherapy|March 28, 2018
Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorderAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Acta Biomaterialia|March 3, 2019
Hypoxia mimicking hydrogels to regulate the fate of transplanted stem cellsBinulal N Sathy, Andrew Daly, Tomas Gonzalez-Fernandez, et al.
Cytotherapy|August 10, 2021
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulinRutvij A Khanolkar, Amit Kalra, Megan Kinzel, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
Clinical Transplantation|June 24, 2020
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low-dose total body irradiation, and rabbit antithymocyte globulinSamar Ousia, Amit Kalra, Tyler S Williamson, et al.
Transplantation and Cellular Therapy|October 4, 2021
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell TransplantationMegan Kinzel, Michelle Dowhan, Amit Kalra, et al.
Pageof 10